Literature DB >> 27866304

Cell lineage determinants as regulators of breast cancer metastasis.

Wei Lu1, Yibin Kang2.   

Abstract

The mammary epithelium is organized in a hierarchy of mammary stem cells (MaSCs), progenitors, and differentiated cells. The development and homeostasis of mammary gland are tightly controlled by a complex network of cell lineage regulators. These determinants of cellular hierarchy are frequently deregulated in breast tumor cells and closely associated with cancer progression and metastasis. They also contribute to the diversity of breast cancer subtypes and their distinct metastatic patterns. Cell fate regulators that normally promote stem/progenitor activities can serve as drivers for epithelial-mesenchymal transition and metastasis whereas regulators that promote terminal differentiation generally suppress metastasis. In this review, we discuss how some of the key factors function in normal mammary lineage determination and how these processes are hijacked by tumor cells to enhance metastasis. Understanding the molecular connections between normal development and cancer metastasis will enable the development of more specific and effective therapeutic approaches targeting metastatic tumor cells.

Entities:  

Keywords:  Breast cancer; EMT; Lineage determinant; Luminal progenitor; Mammary stem cell; Metastasis

Mesh:

Year:  2016        PMID: 27866304     DOI: 10.1007/s10555-016-9644-y

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  3 in total

1.  Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα+ Mammary Carcinomas.

Authors:  Michael P Shea; Kathleen A O'Leary; Saja A Fakhraldeen; Vincent Goffin; Andreas Friedl; Kari B Wisinski; Caroline M Alexander; Linda A Schuler
Journal:  Cancer Res       Date:  2018-01-23       Impact factor: 12.701

2.  Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers.

Authors:  William L Harryman; Kendra D Marr; Ray B Nagle; Anne E Cress
Journal:  Front Cell Dev Biol       Date:  2022-03-01

3.  MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity.

Authors:  Tania Capeloa; Joanna Krzystyniak; Donatienne d'Hose; Amanda Canas Rodriguez; Valery L Payen; Luca X Zampieri; Justine A Van de Velde; Zohra Benyahia; Erica Pranzini; Thibaut Vazeille; Maude Fransolet; Caroline Bouzin; Davide Brusa; Carine Michiels; Bernard Gallez; Michael P Murphy; Paolo E Porporato; Pierre Sonveaux
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.